Promising FDA-approved drugs with efflux pump inhibitory activities against clinical isolates of Staphylococcus aureus

BACKGROUND AND OBJECTIVES: Staphylococcus aureus is an opportunistic pathogen that causes wide range of nosocomial and community-acquired infections which have spread worldwide leading to an urgent need for developing effective anti-staphylococcal agents. Efflux is an important resistance mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Karim, Safaa Abdel-Aal Mohamed, El-Ganiny, Amira Mohamed Ali, El-Sayed, Mona Abdelmonem, Abbas, Hisham Abdelmonem Abdelhamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337675/
https://www.ncbi.nlm.nih.gov/pubmed/35905077
http://dx.doi.org/10.1371/journal.pone.0272417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337675/
https://www.ncbi.nlm.nih.gov/pubmed/35905077
http://dx.doi.org/10.1371/journal.pone.0272417

Ejemplares similares